These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38523597)

  • 1. CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting miR-330-3p/KLF10 axis.
    Yang XX; Wang C
    Kaohsiung J Med Sci; 2024 Apr; 40(4):324-334. PubMed ID: 38523597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
    Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response.
    Zhang Y; Li Z; Zhang Y; Shen C; Zhang Z; Ren X; Guo C; Yang S; Wang Z; Hu H
    Cell Transplant; 2023; 32():9636897231165874. PubMed ID: 37026617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.
    Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X
    Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
    Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
    Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion.
    Wang C; Yang X
    Int Immunopharmacol; 2024 Apr; 131():111613. PubMed ID: 38489970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H
    Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p.
    Yang J; Qi M; Fei X; Wang X; Wang K
    Cell Death Dis; 2022 Apr; 13(4):322. PubMed ID: 35396504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
    Mao W; Huang X; Wang L; Zhang Z; Liu M; Li Y; Luo M; Yao X; Fan J; Geng J
    J Exp Clin Cancer Res; 2019 Apr; 38(1):169. PubMed ID: 30999937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircZNF609 promotes bladder cancer progression and inhibits cisplatin sensitivity via miR-1200/CDC25B pathway.
    Feng D; Lv J; Li K; Cao Q; Han J; Yu H; Cheng Y; Zhuang J; Cai L; Yang H; Yang X; Lu Q
    Cell Biol Toxicol; 2023 Oct; 39(5):1-18. PubMed ID: 35567596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Bi J; Liu H; Dong W; Xie W; He Q; Cai Z; Huang J; Lin T
    Mol Cancer; 2019 Sep; 18(1):133. PubMed ID: 31481066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.
    Zhu QL; Zhan DM; Chong YK; Ding L; Yang YG
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8806-8812. PubMed ID: 31696467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. circRNA circFUT8 Upregulates Krüpple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p.
    He Q; Yan D; Dong W; Bi J; Huang L; Yang M; Huang J; Qin H; Lin T
    Mol Ther Oncolytics; 2020 Mar; 16():172-187. PubMed ID: 32072011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p/MAPK1 axis.
    Yi J; Ma X; Ying Y; Liu Z; Tang Y; Shu X; Sun J; Wu Y; Lu D; Wang X; Luo J; Liu B; Zheng X; Lin Y; Li J; Xie L
    Cancer Lett; 2024 Mar; 585():216613. PubMed ID: 38211649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA CircITGA7 Promotes Tumorigenesis of Osteosarcoma via miR-370/PIM1 Axis.
    Fang C; Wang X; Guo D; Fang R; Zhu T
    Comput Math Methods Med; 2020; 2020():1367576. PubMed ID: 32963582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
    Hao J; Du X; Lv F; Shi Q
    J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
    Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
    Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
    Lu Q; Liu T; Feng H; Yang R; Zhao X; Chen W; Jiang B; Qin H; Guo X; Liu M; Li L; Guo H
    Mol Cancer; 2019 Jun; 18(1):111. PubMed ID: 31228937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.